Home » Stocks » SEER

Seer, Inc. (SEER)

Stock Price: $83.77 USD 4.29 (5.40%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
Market Cap 5.05B
Revenue (ttm) 378,000
Net Income (ttm) n/a
Shares Out 58.82M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $83.77
Previous Close $79.48
Change ($) 4.29
Change (%) 5.40%
Day's Open 79.93
Day's Range 79.20 - 86.55
Day's Volume 270,615
52-Week Range 54.01 - 86.55

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

Combination of Thermo Fisher's market leading Orbitrap mass spectrometer portfolio with Seer Proteographâ„¢ Product Suite to expand availability of end-to-end proteomics in new markets Combinati...

GlobeNewsWire - 2 weeks ago

REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, de...

Benzinga - 1 month ago

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider b...

Other stocks mentioned: CAR, ARDX, CNNE, MPLN, SBTX
GlobeNewsWire - 1 month ago

REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and s...

Seeking Alpha - 1 month ago

The first week of the December IPO market saw eight IPOs and ten SPACs raise $3.9 billion, led by Chinese education technology group 17 Education & Technology Group. Two companies, Ondas and A...

Other stocks mentioned: FTCVU, KNTE, LOKBU, POWW, SBTX, SGAMU, YQ
Investors Business Daily - 1 month ago

The hot category of initial public offerings in the biotechnology sector continues, with two set to trade Friday: Seer and Silverback Therapeutics. Both priced above their estimated range.

Other stocks mentioned: SBTX
GlobeNewsWire - 1 month ago

REDWOOD CITY, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and s...

TheStreet - 2 months ago

Redwood City, California-based Seer was founded to develop instruments to analyze proteins for basic research and discovery.

NASDAQ - 2 months ago

Seer, which provides a proteograph product suite for biomedical research, filed on Thursday with the SEC to raise up to $150 million in an initial public offering.

SEC - 2 months ago

Seer, Inc. has filed to go public with an IPO on the NASDAQ.

About SEER

Seer, a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. The company develops Proteograph, an integrated solution comprising consumables, automation instrumentation, and proprietary software that performs proteomics analysis. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The... [Read more...]

Industry
Biotechnology
IPO Date
Dec 4, 2020
CEO
Omid Farokhzad
Employees
60
Stock Exchange
NASDAQ
Ticker Symbol
SEER
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Seer, Inc stock is "Buy." The 12-month stock price forecast is 69.67, which is a decrease of -16.83% from the latest price.

Price Target
$69.67
(-16.83% downside)
Analyst Consensus: Buy